UrgoStart® heals 60% more patients compared to a well-managed standard treatment, and reduces healing time by 60 days (compared to...
Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved...
Micell® Technologies, Inc., a privately-held, development-stage biomedical company, provided an update on its recently expanded intellectual property portfolio. With the...
BioArctic AB announced that the company has received approval by the Norwegian Medicines Agency (NOMA) departments for medicinal products and...
To help ensure more affordable and timely access to patients most in need, Sanofi and Regeneron Pharmaceuticals, will offer U.S....
The European Medicines Agency (EMA) announced the recommended immediate suspension and recall of AbbVie and Biogen’s multiple sclerosis (MS) drug...
He is a medical doctor by training but it is big data and its implications that is engaging his attention...
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Andy...
Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell...
Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
